Developing fast imaging techniques to analyze brain tissue for Alzheimer's disease
High-speed hyperspectral imaging for highly multiplexed immunofluorescence imaging
['FUNDING_SBIR_1'] · NUMENTUS TECHNOLOGIES INC. · NIH-10699518
This study is looking at new ways to take pictures of brain tissue to help doctors better understand and diagnose Alzheimer's disease, so patients can get more accurate and effective treatments.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NUMENTUS TECHNOLOGIES INC. (nih funded) |
| Locations | 1 site (MENLO PARK, UNITED STATES) |
| Trial ID | NIH-10699518 on ClinicalTrials.gov |
What this research studies
This research focuses on improving imaging techniques to analyze brain tissue samples, specifically for conditions like Alzheimer's disease. By utilizing advanced hyperspectral imaging, the project aims to enable the detection of multiple molecular targets in a single tissue sample quickly and cost-effectively. This approach seeks to enhance the capabilities of traditional immunohistochemistry methods, which are currently limited in their ability to analyze complex networks of proteins. Patients may benefit from more accurate and efficient diagnostic tools that can lead to better understanding and treatment of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with other types of dementia not related to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnostic methods for Alzheimer's disease, improving patient care.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for similar applications, indicating potential for success in this area.
Where this research is happening
MENLO PARK, UNITED STATES
- NUMENTUS TECHNOLOGIES INC. — MENLO PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FARIS, GREGORY W — NUMENTUS TECHNOLOGIES INC.
- Study coordinator: FARIS, GREGORY W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease